What you should know about the new Alzheimer’s drug

An older man rests his chin on his cane while sitting down at a table

In a highly anticipated announcement, the US Food and Drug Administration last week approved the first new drug for Alzheimer’s disease in nearly two decades.

That approval was not without controversy. Both before and after the FDA’s decision, physicians and researchers expressed a wide variety of perspectives on the drug’s potential, given a limited evidence base, and multiple stops and starts in its development and approval process.

The Alzheimer’s drug, called aducanumab during development and clinical trials, will be branded and sold as Aduhelm.

“I really believe this kicks off a new era in the fight against Alzheimer’s disease,” says Stephen Salloway, professor of neurology and psychiatry at Brown University who has been closely involved with the drug’s clinical development since the beginning.

Salloway directs the Memory and Aging Program at Butler Hospital and has been researching Alzheimer’s disease for 30 years.


 Get The Latest By Email

Weekly Magazine Daily Inspiration

He was a site principal investigator at Butler for both Phase 1 and Phase 3 trials of aducanumab, co-chair of the investigative steering committee for the Phase 3 program, and has advised the drug’s manufacturer, Biogen, on safety protocols and side effect management.

Here, he explains the key takeaways from the FDA’s headline-making decision and what it means for Alzheimer’s patients and for future research of the disease:

About The Author

Corrie Pikul-Brown

books_health

This article originally appeared on Futurity

AVAILABLE LANGUAGES

English Afrikaans Arabic Chinese (Simplified) Chinese (Traditional) Danish Dutch Filipino Finnish French German Greek Hebrew Hindi Hungarian Indonesian Italian Japanese Korean Malay Norwegian Persian Polish Portuguese Romanian Russian Spanish Swahili Swedish Thai Turkish Ukrainian Urdu Vietnamese

follow InnerSelf on

facebook icontwitter iconyoutube iconinstagram iconpintrest iconrss icon

 Get The Latest By Email

Weekly Magazine Daily Inspiration

Wednesday, 28 April 2021 08:57

Replenishing antioxidants in the body may help protect against oxidative stress and lower the risk of cancer

Thursday, 20 May 2021 08:31

It’s recommended we do at least 30 minutes of exercise a day – or 150 minutes a week – to stay healthy. But 30 minutes accounts for just 2% of the day. And many of us spend most of the rest of the...

Wednesday, 19 May 2021 08:07

For many people, the thing they’ve missed most during the pandemic is being able to hug loved ones. Indeed, it wasn’t until we lost our ability to hug friends and family did many realise just how...

Thursday, 27 May 2021 05:24

Life, by its very nature is … alive! Because it is alive, it is not just responding in a set, mechanical way, but rather it is responsive to what is needed and helpful and useful. Cells might...

Monday, 24 July 2023 16:37

Uterine fibroids, or leiomyomas, are benign tumors commonly occurring in the uterus. They affect many women, particularly African Americans, and can lead to clinical symptoms such as abnormal...

Wednesday, 26 May 2021 08:54

The term “exercise is medicine” is rightfully well publicised. It’s one of the best ways to stay healthy, yet medicine doesn’t work if you aren’t prepared to take it.

New Attitudes - New Possibilities

InnerSelf.comClimateImpactNews.com | InnerPower.net
MightyNatural.com | WholisticPolitics.com | InnerSelf Market
Copyright ©1985 - 2021 InnerSelf Publications. All Rights Reserved.